Online citations, reference lists, and bibliographies.
← Back to Search

Toxicity Testing In The 21st Century: A Vision And A Strategy

D. Krewski, D. Acosta, M. Andersen, H. Anderson, J. Bailar, K. Boekelheide, R. Brent, G. Charnley, V. Cheung, S. Green, K. Kelsey, N. Kerkvliet, Abby A. Li, Lawrence E Mccray, O. Meyer, Reid Patterson, W. Pennie, R. Scala, G. Solomon, M. Stephens, J. Yager, L. Zeise, Staff of Committee on Toxicity Testing and Assessm
Published 2010 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
With the release of the landmark report Toxicity Testing in the 21st Century: A Vision and a Strategy, the U.S. National Academy of Sciences, in 2007, precipitated a major change in the way toxicity testing is conducted. It envisions increased efficiency in toxicity testing and decreased animal usage by transitioning from current expensive and lengthy in vivo testing with qualitative endpoints to in vitro toxicity pathway assays on human cells or cell lines using robotic high-throughput screening with mechanistic quantitative parameters. Risk assessment in the exposed human population would focus on avoiding significant perturbations in these toxicity pathways. Computational systems biology models would be implemented to determine the dose-response models of perturbations of pathway function. Extrapolation of in vitro results to in vivo human blood and tissue concentrations would be based on pharmacokinetic models for the given exposure condition. This practice would enhance human relevance of test results, and would cover several test agents, compared to traditional toxicological testing strategies. As all the tools that are necessary to implement the vision are currently available or in an advanced stage of development, the key prerequisites to achieving this paradigm shift are a commitment to change in the scientific community, which could be facilitated by a broad discussion of the vision, and obtaining necessary resources to enhance current knowledge of pathway perturbations and pathway assays in humans and to implement computational systems biology models. Implementation of these strategies would result in a new toxicity testing paradigm firmly based on human biology.
This paper references
Appraisal of the safety of chemicals in foods, drugs and cosmetics
Food (1959)
10.5694/j.1326-5377.1960.tb73127.x
The Principles of Humane Experimental Technique
W. Russell (1960)
Drinking water and health, Vol
National Research Council. (1977)
10.4135/9781412953924.n362
The Environmental Protection Agency
P. Stolpman (1982)
Risk Assessment in the Federal Government: Managing the Process
Division on Earth (1983)
Guidelines for carcinogen risk assessment
U. Epa (1986)
10.1111/J.1539-6924.1986.TB00954.X
Improving risk communication.
R. Keeney (1986)
10.17226/921
Drinking Water and Health
R. D. Thomas (1986)
10.1038/324029a0
Cost-effectiveness of short-term tests for carcinogenicity
L. Lave (1986)
Pesticide regulation handbook. New York: Executive Enterprises Publication
J. D. Conner (1987)
10.1016/0273-2300(88)90039-6
Toxicokinetics in the evaluation of toxicity data.
P. Watanabe (1988)
10.1016/0378-4274(88)90031-8
Modeling the tissue solubilities and metabolic rate constant (Vmax) of halogenated methanes, ethanes, and ethylenes.
M. Gargas (1988)
10.1038/336631A0
Information value of the rodent bioassay
L. Lave (1988)
Complex mixtures: Methods for in vivo toxicity testing
National Research Council. (1988)
10.1021/JM00128A051
Lipophilic analogues of sparsomycin as strong inhibitors of protein synthesis and tumor growth: a structure-activity relationship study.
L. V. D. van den Broek (1989)
10.1016/0041-008X(89)90137-3
Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues.
M. Gargas (1989)
Environmental Protection Agency. Comments on EPA's strategic research directions and research budget for FY 2008, An advisory report of the US Environmental Protection Agency Science Advisory Board
L A Broek (1989)
10.1111/J.1539-6924.1990.TB01053.X
Two-event model for carcinogenesis: biological, mathematical, and statistical considerations.
S. Moolgavkar (1990)
10.1016/0041-008X(90)90148-N
Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling.
R. Reitz (1990)
10.1111/J.1539-6924.1990.TB00528.X
Uncertainties in pharmacokinetic modeling for perchloroethylene. I. Comparison of model structure, parameters, and predictions for low-dose metabolism rates for models derived by different authors.
D. Hattis (1990)
10.2965/JSWE1978.14.437
OECD (経済開発協力機構) : Organization for Economic Co-operation and Development
正弘 中舘 (1991)
Pesticide Regulation Handbook
M. Cuneo (1992)
New concepts in steroid hormone action: transcription factors, proto-oncogenes, and the cascade model for steroid regulation of gene expression.
J. Landers (1992)
Issues in risk assessment
National Research Council. (1993)
A Primer on health risk communication principles and practices
Max R. Lum (1994)
10.1016/0006-2952(94)90434-0
Drug-metabolizing enzymes in ligand-modulated transcription.
D. Nebert (1994)
10.1111/J.1539-6924.1995.TB00314.X
Modeling human interindividual variability in metabolism and risk: the example of 4-aminobiphenyl.
F. Bois (1995)
10.1016/0300-483X(95)03239-C
Toxicology of chemical mixtures: challenges for today and the future.
V. Feron (1995)
10.1007/s002040050284
Population toxicokinetics of tetrachloroethylene
F. Bois (1996)
10.1007/s002040050331
Physiologically based pharmacokinetic/pharmacodynamic modeling of the toxicologic interaction between carbon tetrachloride and Kepone
H. El-Masri (1996)
10.1111/J.1539-6924.1996.TB01092.X
A biologically-based dose-response model for developmental toxicology.
B. Leroux (1996)
10.5860/choice.34-5653
Understanding Risk - Informing Decisions in a Democratic Society
ed. P C Stern (1996)
10.1016/S0378-4274(96)90054-5
Casarett and Doull's toxicology: The basic science of poisons
J. Pickrell (1996)
Physiologically based pharmacokinetic/pharmacodynamic modeling
H. A. el-Masri (1996)
10.1088/0952-4746/17/3/020
Understanding Risk - Informing Decisions in a Democratic Society
Mary Morris (1997)
10.1016/S0890-6238(96)00153-0
Advances in understanding mechanisms of toxicity and implications for risk assessment.
G. Daston (1997)
Agency for Toxic Substances and Disease Registry.
Foreword (1997)
10.1016/S0378-4274(98)00315-4
Testing strategies in immunotoxicology.
M. Pallardy (1998)
10.1016/S0899-9007(97)98988-X
The Food Quality Protection Act of 1996.
M. Glade (1998)
10.1080/10408449891344164
Toxicological evaluation and risk assessment of chemical mixtures.
F. Cassee (1998)
10.1037/e519322012-001
Guidelines for Neurotoxicity Risk Assessment
H. Tilson (1998)
Guidelines for ecological risk assessment
U. Epa (1998)
10.1289/EHP.98106775
Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife.
M. van den Berg (1998)
10.11234/GI1990.9.151
A System for Identifying Genetic Networks from Gene Expression Patterns Produced by Gene Disruptions and Overexpressions.
Akutsu (1998)
Environmental Protection Agency, Risk Assessment Forum. Available at oaspub.epa.gov/ eims/eimscomm.getfile?
(1998)
Environmental Protection Agency. Health effects test guidelines: OPPTS 870.4300 combined chronic toxicity/carcinogenicity
(1998)
Health effects test guidelines: OPPTS 870.4300 combined chronic toxicity/carcinogenicity. EPA 712-C-98-212
(1998)
QSAR in aquatic toxicology: A mechanism of action approach comparing toxic potency to Pimephales promelas, Tetrahymena pyriformis, and Vibrio fischeri
T. W. Schultz (1998)
Guidelines for neurotoxicity risk assessment. EPA/630/R-95/001F
(1998)
10.1016/S0168-3659(99)00040-1
Recent advances in retrometabolic design approaches.
N. Bodor (1999)
10.1097/00004045-199907000-00013
The Department of Health and Human Services.
J. Stoker (1999)
REPLACING ANIMAL TESTING BY VIRTUAL EXPERIMENTS : A CHALLENGE IN COMPUTATIONAL CHEMISTRY
A. Vedani (1999)
10.1006/ABBI.1999.1351
P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR.
D. Waxman (1999)
10.1016/S1084-8592(99)80011-3
Technologies for detecting genetic polymorphisms in pharmacogenomics.
M. M. Shi (1999)
Replacing animal testing by virtual experiments: A challenge in computational biology
A. Vedani (1999)
10.1093/TOXSCI/56.1.8
The practice of structure activity relationships (SAR) in toxicology.
J. McKinney (2000)
10.1016/S0092-8674(00)81693-1
Genomic Biology
R Brent (2000)
10.1126/SCIENCE.287.5459.1777
Journey to the Center of Biology
E. Lander (2000)
10.1146/ANNUREV.PHARMTOX.40.1.335
The impact of genomics-based technologies on drug safety evaluation.
J. Waring (2000)
10.1016/S1078-5337(05)70055-1
Pathophysiology of asthma.
K. McDowell (2000)
10.1016/S0006-2952(99)00291-9
Role of Gadd45 in apoptosis.
M. Sheikh (2000)
10.1016/S0378-5173(00)00422-1
A simple model for the prediction of blood-brain partitioning.
M. Fehér (2000)
10.1126/SCIENCE.287.5462.2431
RNA Interference
P. Sharp (2000)
10.2174/1381612003398906
Positron emission tomography in drug development and drug evaluation.
A. Paans (2000)
Genomics: journey to the center of biology.
E. Lander (2000)
10.1016/S0048-9697(99)00512-4
Health-effects related structure-toxicity relationships: a paradigm for the first decade of the new millennium.
T. Schultz (2000)
10.1046/j.1365-2958.2000.02002.x
Response of Saccharomyces cerevisiae to severe osmotic stress: evidence for a novel activation mechanism of the HOG MAP kinase pathway
O. Van Wuytswinkel (2000)
Ecdysone-regulated puff genes
C S Thummel (2000)
Response of Saccharomyces cerevisiae to sever osmotic stress: Evidence for a novel activation mechanism
O. Van Wuytswinkel (2000)
Insect Biochem Mol Biol
Thummel CS. Ecdysone-regulated puff genes (2000)
Scientific frontiers in developmental toxicology and risk assessment
National Research Council. (2000)
10.2134/JEQ2001.301273X
Hormonally Active Agents in the Environment
G. Webster (2001)
10.1191/0748233701th119oa
Application of in vitro biotransformation data and pharmacokinetic modeling to risk assessment
G. L. Kedderis (2001)
10.17226/6029
Hormonally Active Agents in the Environment
E. Oberdörster (2001)
10.1201/9781420025187.CH2
Human pharmaceutical products
S. Gad (2001)
In the Chamber of Risks: Understanding Risk Controversies
W. Leiss (2001)
10.1080/00498250110060978
High-throughput screening approaches for investigating drug metabolism and pharmacokinetics.
Roberts Sa (2001)
10.2174/1386207013331101
In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery.
C. Masimirembwa (2001)
10.1201/9781420025187.CH10
Industrial chemicals: Regulation of new and existing chemicals (The Toxic Substances Control Act and similar worldwide chemical control laws)
R. Kraska (2001)
10.1080/00498250110060978
High-throughput screening approaches for investigating drug metabolism and pharmacokinetics
S. Roberts (2001)
10.1016/S0887-2333(01)00060-1
Computer-modeling-based QSARs for analyzing experimental data on biotransformation and toxicity.
A. E. Soffers (2001)
10.1016/S0887-2333(01)00070-4
Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice.
H. Spielmann (2001)
10.1038/ng1201-365
Minimum information about a microarray experiment (MIAME)—toward standards for microarray data
A. Brazma (2001)
10.1201/9781420025187
Regulatory Toxicology, Second Edition
S. Gad (2001)
10.1152/PHYSREV.2001.81.3.1269
Nuclear hormone receptors and gene expression.
A. Aranda (2001)
10.1201/9781420025187.CH5
Food additives and nutrition supplements
V. Frankos (2001)
10.1016/S0048-9697(01)00743-4
Quantitative structure-pharmacokinetic relationship modelling.
M. Fouchécourt (2001)
Association of Food and Drug Officials of the United States; 1959. Staff of the Division of Pharmacology, Food and Drug Administration, Department of Health
Welfare Fouchecourt (2001)
National report on human exposure to environmental chemicals
Centers for Disease Control (2001)
Human pharmaceutical products. In: Gad, SC., editor. Regulatory toxicology
SC. Gad (2001)
editor. In the chamber of risks: Understanding risk controversies. Montreal: McGillQueen’s
W. Leiss (2001)
10.1289/EHP.110-A444
Further Comments on the Bioavailability of D4
ME Andersen (2002)
10.1093/TOXSCI/67.2.159
Dose-response modeling of cytochrome p450 induction in rats by octamethylcyclotetrasiloxane.
R. Sarangapani (2002)
10.1126/SCIENCE.1071914
The IκB-NF-κB Signaling Module: Temporal Control and Selective Gene Activation
A. Hoffmann (2002)
10.1159/000070737
Animal Models for Asthma: Controversial Aspects and Unsolved Problems
R. Pabst (2002)
10.1016/S0300-483X(02)00295-0
The use of biologically based modeling in risk assessment.
R. Conolly (2002)
10.1126/SCIENCE.1068873
MAP Kinase Phosphatase As a Locus of Flexibility in a Mitogen-Activated Protein Kinase Signaling Network
U. Bhalla (2002)
10.1006/TAAP.2002.9525
Necrosis of nasal and airway epithelium in rats inhaling vapors of artificial butter flavoring.
A. Hubbs (2002)
10.1006/RTPH.2002.1570
Support of science-based decisions concerning the evaluation of the toxicology of mixtures: a new beginning.
L. Teuschler (2002)
10.1080/1356182021000008337
The state of the world's pharmacy: a portrait of the pharmacy profession
S. Anderson (2002)
10.1177/026119290203002S12
The Current Status and Future Applicability of Quantitative Structure–activity Relationships (QSARs) in Predicting Toxicity
M. Cronin (2002)
10.1002/JPS.10128
Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
P. Poulin (2002)
10.1289/EHP.02110S1103
Diesel exhaust and asthma: hypotheses and molecular mechanisms of action.
R. Pandya (2002)
10.1002/JPS.10005
Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution.
P. Poulin (2002)
10.1016/S1359-6446(02)02385-1
Expanding the HTS paradigm.
James Inglese (2002)
10.1056/NEJMOA020300
Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant.
K. Kreiss (2002)
10.1016/S0965-1748(01)00112-6
Ecdysone-regulated puff genes 2000.
C. Thummel (2002)
10.1038/nbt746
Arrayed adenoviral expression libraries for functional screening
F. Michiels (2002)
10.1289/EHP.02110S6971
Molecular circuits, biological switches, and nonlinear dose-response relationships.
M. Andersen (2002)
Evaluation of SAR predictions of estrogen receptor binding affinity. EPA/68-W-01-023. Work Assignment 2-3. Prepared for
Battelle (2002)
Environmental Protection Agency. Food Quality Protection Act (FQPA) of 1996. U.S. Environmental Protection Agency, Office of Pesticides
(2002)
Ecological risk assessment: History and fundamentals
A. Sergeant (2002)
Evaluation of SAR predictions of estrogen receptor binding affinity
Battelle. (2002)
Bronchiolitis obliterans syndrome in popcorn plant workers
M. Akpinar-Elci (2002)
Bronchiolits obliterans in the food flavoring manufacturing industry
J. Lockey (2002)
10.1101/GR.1195703
Investigations Into the Analysis and Modeling of the TNFα-Mediated NF-κB-Signaling Pathway
K. Cho (2003)
10.1126/SCIENCE.1081403
Identification of Hedgehog Pathway Components by RNAi in Drosophila Cultured Cells
L. Lum (2003)
10.1897/01-627
Guidelines for developing and using quantitative structure-activity relationships.
John D. Walker (2003)
10.1016/S0898-6568(02)00115-8
Nuclear receptors: integration of multiple signalling pathways through phosphorylation.
C. Rochette-Egly (2003)
10.1210/EN.2003-0567
Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype.
J. Frasor (2003)
10.1080/713608373
A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action
M. E. Meek (2003)
10.1093/TOXSCI/KFG182
Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat.
R. Conolly (2003)
10.1897/01-198
Structure-activity relationship approaches and applications.
W. Tong (2003)
10.1897/02-568
Quantitative cationic-activity relationships for predicting toxicity of metals.
John D. Walker (2003)
10.2174/1568026033452014
Role of ADME characteristics in drug discovery and their in silico evaluation: in silico screening of chemicals for their metabolic stability.
V. Gombar (2003)
10.5860/choice.34-3899
Principles of Toxicology
M. Davis (2003)
10.1073/pnas.1934839100
Genome-scale functional profiling of the mammalian AP-1 signaling pathway
S. Chanda (2003)
10.1080/713610025
Human and Ecological Risk Assessment: Theory and Practice
D. Paustenbach (2003)
10.1016/J.MOLBRAINRES.2003.08.018
In vivo heat-shock response in the brain: signalling pathway and transcription factor activation.
P. Maroni (2003)
10.1016/S0378-4274(02)00374-0
Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection.
Frank-Peter Theil (2003)
10.1016/S0278-6915(03)00064-4
Risk characterisation of chemicals in food and diet.
A. Renwick (2003)
10.1074/jbc.M306423200
Use of Proteomics to Demonstrate a Hierarchical Oxidative Stress Response to Diesel Exhaust Particle Chemicals in a Macrophage Cell Line*
G. G. Xiao (2003)
Second national report on human Exposure to Environmental Chemicals
Centers for Disease Control (2003)
10.1016/S1359-6446(03)02971-4
Early prediction of drug metabolism and toxicity: systems biology approach and modeling.
A. Bugrim (2004)
10.1529/BIOPHYSJ.104.040501
Signaling in small subcellular volumes. II. Stochastic and diffusion effects on synaptic network properties.
U. Bhalla (2004)
10.1007/BF00756514
Interest and limits of human tissue and cell use in pharmacotoxicology
M. Potier (2004)
10.1016/J.TAAP.2004.06.027
Dose-dependent transitions in mechanisms of toxicity: case studies.
W. Slikker (2004)
10.1016/J.MOLMED.2004.09.003
Nrf2-Keap1 defines a physiologically important stress response mechanism.
H. Motohashi (2004)
10.1016/J.COLSURFB.2004.04.006
Correlation between structure and transfection efficiency: a study of DC-Chol--DOPE/DNA complexes.
A. Congiu (2004)
10.1111/J.0272-4332.2004.00561.X
Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment.
L. H. Clark (2004)
10.1038/nature02371
A large-scale RNAi screen in human cells identifies new components of the p53 pathway
K. Berns (2004)
Trends in environmentally related childhood illnesses.
T. Woodruff (2004)
Development of an in vitro model for vascular injury with human endothelial cells.
C. Schleger (2004)
10.1177/026119290403200417
Strategies to Replace in Vivo Acute Systemic Toxicity Testing: The Report and Recommendations of ECVAM Workshop 501,2
A. Gennari (2004)
Vagus nerve participates in regulation of the airways: inflammatory response and hyperreactivity induced by occupational asthmogens.
W. Lutz (2004)
10.1016/J.TCB.2004.10.007
Computational approaches for modeling regulatory cellular networks.
N. J. Eungdamrong (2004)
10.5751/ES-00694-090601
Challenges in regulating pesticide mixtures
M. Lydy (2004)
10.1128/MCB.24.16.7130-7139.2004
Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2
A. Kobayashi (2004)
10.1073/PNAS.0308562100
Identification of p53 regulators by genome-wide functional analysis.
Q. Huang (2004)
10.1016/J.TAAP.2004.06.019
Dose-dependent transitions in mechanisms of toxicity.
W. Slikker (2004)
10.1109/IEMBS.2004.1403853
Knowledge-based algorithms for chemical structure and property analysis
P. Volarath (2004)
10.1038/nrg1272
Network biology: understanding the cell's functional organization
A. Barabasi (2004)
10.1111/J.0272-4332.2004.00555.X
Tiered chemical testing: a value of information approach.
Fumie Yokota (2004)
10.1038/nature02873
Mechanisms of gene silencing by double-stranded RNA
G. Meister (2004)
10.1038/nature02872
Revealing the world of RNA interference
Craig C. Mello (2004)
10.1159/000076131
Do Mouse Models of Allergic Asthma Mimic Clinical Disease?
M. Epstein (2004)
10.1511/2004.45.921
Human Biomonitoring of Environmental Chemicals
K. Sexton (2004)
10.1529/BIOPHYSJ.104.040469
Signaling in small subcellular volumes. I. Stochastic and diffusion effects on individual pathways.
U. Bhalla (2004)
10.1093/TOXSCI/KFH223
Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset.
R. Conolly (2004)
10.1093/ILAR.45.4.494
In vitro models in endocrine disruptor screening.
G. Charles (2004)
Chemical structure of mutagens and carcinogens and the relationship with biological activity.
R. Benigni (2004)
10.1111/J.0272-4332.2004.453_3.X
In the Chamber of Risks: Understanding Risk Controversies
Jennifer Vanderhart (2004)
Public health goal for arsenic in drinking water
(2004)
Correlation between structure and transfection efficiency: A study of DC-Chol-DOPE/DNA complexes. Colloids Surf B Biointerfaces
A Congiu (2004)
Quantitative structure–activity relationships for pollution prevention, toxicity screening, risk assessment, and web applications (QSAR II). Pensacola, FL: SETAC
Walker (2004)
Mechanisms of gene slicing by double-stranded RNA
G. Meister (2004)
Oxidative stress sensor Keap1 functions as an adaptor for CuI3based E3 ligase to regulate proteasomal
A. Kobayashi (2004)
Life stages white paper
International Life Sciences Institute Health (2004)
Signaling in small subcellular volumes
U. S. Bhalla (2004)
Human respiratory tract cancer risks of inhaled formaldehyde: Doseresponse predictions derived from biologi
R. B. Conolly (2004)
Public health goal for arsenic in drinking water
California Environmental Protection Agency. (2004)
Revealing the world of RNA
CC Mello (2004)
Quantitative structure–activity relationships for pollution prevention, toxicity screening, risk assessment, and web applications (QSAR II)
J. D. Walker (2004)
Systemic toxicity white paper
International Life Sciences Institute Health (2004)
Trends in environmentally related childhood
TJ Woodruff (2004)
10.1093/MUTAGE/GEI058
Risk assessment of welders using analysis of eight metals by ICP-MS in blood and urine and DNA damage evaluation by the comet and micronucleus assays; influence of XRCC1 and XRCC3 polymorphisms.
G. Iarmarcovai (2005)
10.1080/10408440590931994
Evaluation of Physiologically Based Pharmacokinetic Models in Risk Assessment: An Example with Perchloroethylene
H. Clewell (2005)
10.1016/J.ABB.2004.08.030
Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR.
C. Handschin (2005)
10.1126/SCIENCE.1105809
Causal Protein-Signaling Networks Derived from Multiparameter Single-Cell Data
K. Sachs (2005)
10.1016/J.TIPS.2005.02.006
Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity.
S. Ekins (2005)
10.1074/JBC.R500010200
Heat Shock Response Modulators as Therapeutic Tools for Diseases of Protein Conformation*
S. Westerheide (2005)
10.1016/S1387-2656(05)11001-1
Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
H. Fischer (2005)
10.1093/BFGP/4.2.178
A tiered approach to comparative genomics.
T. Ptacek (2005)
10.1016/J.REPROTOX.2004.12.004
Dose-response modeling in reproductive toxicology in the systems biology era.
M. Andersen (2005)
10.1080/15287390590912180
Computational Pharmacokinetics During Developmental Windows of Susceptibility
H. Barton (2005)
10.1042/BJ20050908
Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway.
R. Orton (2005)
10.1016/J.ETP.2005.05.014
Overview of inhalation exposure techniques: strengths and weaknesses.
J. Pauluhn (2005)
10.1080/02652030500309319
Ochratoxin A: Potential epigenetic mechanisms of toxicity and carcinogenicity
B. Schilter (2005)
10.1080/03602530500205309
Studying Cellular Processes and Detecting Disease with Protein Microarrays
R. Zangar (2005)
10.1016/J.REPROTOX.2004.10.003
Application of a systems biology approach to developmental neurotoxicology.
W. Slikker (2005)
Loss of integrin alpha3 expression associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cells.
N. Suzuki (2005)
10.1529/BIOPHYSJ.104.055301
Mathematical modeling of the eukaryotic heat-shock response: dynamics of the hsp70 promoter.
Theodore R. Rieger (2005)
10.17226/11248
Implications of Nanotechnology for Environmental Health Research
L. Goldman (2005)
10.1073/PNAS.0403510102
Surviving heat shock: control strategies for robustness and performance.
H. El-Samad (2005)
10.1038/msb4100011
International alliances for quantitative modeling in systems biology
H. Kitano (2005)
10.1016/J.TIBTECH.2005.01.007
New directions in incidence-dose modeling.
M. Andersen (2005)
10.1634/THEONCOLOGIST.10-2-92
Molecular imaging of antiangiogenic agents.
S. Rehman (2005)
10.1016/j.febslet.2005.08.079
Dicing and slicing
S. Hammond (2005)
10.1016/J.TAAP.2005.01.049
Predicting the risk of developmental toxicity from in vitro assays.
H. Spielmann (2005)
10.1177/026119290503301s15
3.9. Toxicokinetics and Metabolism
S. Coecke (2005)
10.1016/J.TAAP.2004.09.015
Gene expression profiling in mouse lung following polymeric hexamethylene diisocyanate exposure.
Chun-Ting Lee (2005)
10.1080/08958370500225240
Toxicity Assessment of Industrial Chemicals and Airborne Contaminants: Transition from In Vivo to In Vitro Test Methods: A Review
S. Bakand (2005)
10.1016/J.REPROTOX.2004.10.001
A systems biology approach to developmental toxicology.
A. Cummings (2005)
10.1289/ehp.7651
Personalized Exposure Assessment: Promising Approaches for Human Environmental Health Research
B. Weis (2005)
10.1503/CMAJ.045021
Drug withdrawals from the Canadian market for safety reasons, 1963–2004
J. Lexchin (2005)
Food Quality Protection Act (FQPA) of 1996
U. S. Environmental Protection Agency. (2005)
EPA commemorates its history and celebrates its 35th anniversary
U. S. Environmental Protection Agency. (2005)
Third national report on human exposure to environmental chemicals
Centers for Disease Control (2005)
Chemical regulation: Options exist to improve EPA’s ability to assess health risks and manage its chemical review program
Government Accounting Office. (2005)
The OECD: Organization for Economic Co-operation and Development. Organization of Economic Co-operation and Development
Paris (2005)
Food Quality Protection Act (FQPA) of 1996. U.S. Environmental Protection Agency, Office of Pesticides
(2005)
Loss of integrin alpha3 expression is associated with acquisition of invasive
N. Suzuki (2005)
Chemical regulation: Options exist to improve EPA's ability to assess health risks and manage its chemical review program
(2005)
New directions in incidence dose-response modeling
M. E. Andersen (2005)
Paris: Organisation for Economic Co-operation and Development
D. KREWSKI (2005)
Guidance document on the validation and international acceptance of new or updated test methods for hazard assessment
Organization for Economic Cooperation (2005)
History of NTP
National Toxicology Program. (2005)
Report on carcinogens, 11th Ed
National Toxicology Program. (2005)
Nanomaterial health effects--part 1: background and current knowledge.
Maria C Powell (2006)
10.1080/10408440500534354
Agricultural Chemical Safety Assessment: A Multisector Approach to the Modernization of Human Safety Requirements
N. Carmichael (2006)
10.1111/j.1539-6924.2006.00709.x
A Search for Thresholds and Other Nonlinearities in the Relationship Between Hexavalent Chromium and Lung Cancer
Robert M. Park (2006)
10.1021/JM060551L
Prediction of activation energies for hydrogen abstraction by cytochrome p450.
L. Olsen (2006)
10.1016/B978-012088786-6/50020-4
Introducing computational systems biology
A. Kriete (2006)
10.1038/SCIENTIFICAMERICAN0106-84
Protecting more than animals.
A. Goldberg (2006)
10.1111/j.1742-4658.2006.05225.x
Regulated cleavage of intracellular glycosylphosphatidylinositol in a trypanosome
S. Subramanya (2006)
10.1177/153303460600500208
Bioinformatics for Cancer Management in the Post-Genome Era
Masuko Katoh (2006)
Cobalt in hard metals and cobalt sulfate, gallium arsenide, indium phosphide and vanadium pentoxide.
M. Altamirano-Lozano (2006)
10.1073/PNAS.0604348103
Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries.
James Inglese (2006)
10.1080/03602530600971974
Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway
Donna D. Zhang (2006)
10.1080/10408440500534362
The Acquisition and Application of Absorption, Distribution, Metabolism, and Excretion (ADME) Data in Agricultural Chemical Safety Assessments
H. Barton (2006)
10.1400/52970
Towards an understanding of the role of forces in carcinogenesis: a perspective with therapeutic implications.
M. Lieber (2006)
10.1586/14737159.6.2.179
Translating genomic biomarkers into clinically useful diagnostics
G. Ginsburg (2006)
10.1038/nrg1809
Microarray technology: beyond transcript profiling and genotype analysis
J. Hoheisel (2006)
10.2174/157016306776637564
Rational design approaches to chemical libraries for hit identification.
K. Balakin (2006)
10.1289/ehp.8871
Nanoparticles: Health Effects—Pros and Cons
M. Gwinn (2006)
10.1016/J.DRUDIS.2006.08.015
High-content screening moves to the front of the line.
S. Haney (2006)
10.1016/J.JACI.2006.06.006
Pro-oxidative diesel exhaust particle chemicals inhibit LPS-induced dendritic cell responses involved in T-helper differentiation.
R. C. Chan (2006)
10.1158/0008-5472.CAN-06-0516
Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4.
Shuk-Mei Ho (2006)
10.1016/J.ETP.2005.10.003
Safety assessment of high fructose corn syrup (HFCS) as an ingredient added to cigarette tobacco.
M. Stavanja (2006)
10.1177/026119290603400604
The Principles of Weight of Evidence Validation of Test Methods and Testing Strategies
M. Balls (2006)
10.1289/ehp.9008
Arsenic Exposure Is Associated with Decreased DNA Repair in Vitro and in Individuals Exposed to Drinking Water Arsenic
A. Andrew (2006)
10.1080/10408440500534370
A Tiered Approach to Systemic Toxicity Testing for Agricultural Chemical Safety Assessment
J. Doe (2006)
10.1210/ME.2005-0186
Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action.
W. R. Harrington (2006)
10.1016/J.ADVENZREG.2006.01.007
Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species.
M. Kobayashi (2006)
10.1074/jbc.M601119200
Dimerization of Substrate Adaptors Can Facilitate Cullin-mediated Ubiquitylation of Proteins by a “Tethering” Mechanism
M. McMahon (2006)
10.1158/0008-5472.CAN-06-2298
Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents.
X. Wang (2006)
10.1016/J.VASCN.2005.05.005
Systems-ADME/Tox: resources and network approaches.
S. Ekins (2006)
10.1201/9781420015737.ch11
Three-Dimensional Structures in Target Discovery and Validation
Andrea Schafferhans (2006)
10.1186/1471-2105-7-420
Comparative assessment of performance and genome dependence among phylogenetic profiling methods
Evan S. Snitkin (2006)
10.1038/ncb1497
Physicochemical modelling of cell signalling pathways
B. B. Aldridge (2006)
10.1016/J.COPBIO.2006.09.003
High-throughput human metabolism and toxicity analysis.
M. Lee (2006)
10.1515/BC.2006.144
The impact of aryl hydrocarbon receptor signaling on matrix metabolism: implications for development and disease
J. Hillegass (2006)
Structure-activity models of chemical carcinogens: state of the art, and new directions.
R. Benigni (2006)
10.1289/ehp.9466
Urinary Perchlorate and Thyroid Hormone Levels in Adolescent and Adult Men and Women Living in the United States
B. Blount (2006)
10.1016/S0379-4172(06)60122-4
Microarray analysis of gene-expression profile in hepatocellular carcinoma cell, BEL-7402, with stable suppression of hLRH-1 via a DNA vector-based RNA interference.
Shui-liang Wang (2006)
Advances in systems biology: measurement, modeling and representation.
Susie M Stephens (2006)
The Principles of Weight of Evidence Validation of Test Methods and Testing Strategies
Balls Michael (2006)
Integrated mechanistic and data-driven modelling for multivariate analysis of signalling pathways
FeiHua (2006)
10.1126/SCIENCE.1114397
Toxic Potential of Materials at the Nanolevel
A. Nel (2006)
10.1177/026119290603400113
Metabolism: A Bottleneck in In Vitro Toxicological Test Development
S. Coecke (2006)
10.1186/1743-8977-3-11
The potential risks of nanomaterials: a review carried out for ECETOC
P. Borm (2006)
10.1098/rsif.2005.0109
Integrated mechanistic and data-driven modelling for multivariate analysis of signalling pathways
F. Hua (2006)
10.1016/J.TOX.2006.04.032
Use of computer-assisted prediction of toxic effects of chemical substances.
B. Simon-Hettich (2006)
10.1159/000097357
Role of Cytokines in Allergic Airway Inflammation
H. Nakajima (2006)
10.1289/ehp.8247
Meeting Report: Validation of Toxicogenomics-Based Test Systems: ECVAM–ICCVAM/NICEATM Considerations for Regulatory Use
R. Corvi (2006)
10.1080/10807030600561832
Public Perception of Population Health Risks in Canada: Health Hazards and Sources of Information
D. Krewski (2006)
Systems-ADME/Tox: Resources and network applications
S. Ekins (2006)
Use of computer-assisted prediction of toxic effects of chemical substances. Toxicology
B Simon-Hettich (2006)
Pesticides: Science and policy
U. S. Environmental Protection Agency. (2006)
Quantitative highthroughput screening: A titration-based approach that efficiently identifies biological
J. Inglese (2006)
Advances in systems biology: Measurement, modeling 136 D. KREWSKI ET AL. and representation
S M Stephens (2006)
Review of the Department of Energy’s Genomics: GTL program
National Research Council. (2006)
Physicochemical modeling of cell signaling pathways
B. B. Aldridge (2006)
Current directions and evolving strategies
National Toxicology Program. (2006)
The role of mutagenicity
R. P. Subramaniam (2006)
Resources and network applications
S Ekins (2006)
Highlights of the Food Quality Protection Act of 1996. Office of Pesticides
(2006)
Microarray analysis of gene-expression profile in hepatocellular carcinoma cell, BEL-7402, with stable suppression of hLRH-1 via a DNA vector-based RNA
SL Wang (2006)
Pesticides: Science and policy. Office of Pesticides
(2006)
Science and research budgets for the U.S. Environmental Protection Agency for fiscal year 2007; An advisory report by the Science Advisory Board
(2006)
Microarray analysis of gene-expression profile in hepatocellular carcinoma
S. L. Wang (2006)
10.1152/AJPLUNG.00208.2006
Nonhematopoietic NADPH oxidase regulation of lung eosinophilia and airway hyperresponsiveness in experimentally induced asthma.
H. Abdala-Valencia (2007)
10.1194/jlr.M600282-JLR200
PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine Published, JLR Papers in Press, November 6, 2006.
Tiangang Li (2007)
10.1146/ANNUREV.PHYSCHEM.58.032806.104520
Modeling self-assembly and phase behavior in complex mixtures.
A. C. Balazs (2007)
10.1385/1-59745-217-3:415
In vitro cytotoxicity assessment.
Peter O'Brien (2007)
10.1097/MOL.0b013e328082e4d5
Membrane lipids as signaling molecules
A. Fernandis (2007)
10.1385/CBB:43:1:149
Growing applications and advancements in microarray technology and analysis tools
J. Peeters (2007)
10.1016/j.steroids.2006.12.006
CAR and PXR: The xenobiotic-sensing receptors
Y. Timsit (2007)
10.3892/IJO.30.1.253
Genetic and epigenetic changes induced by chronic low dose exposure to arsenic of mouse testicular Leydig cells.
K. Singh (2007)
10.1038/ncb1543
Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate
Silvia D. M. Santos (2007)
10.1016/j.neuroscience.2006.10.059
Genome instability and DNA damage accumulation in gene-targeted mice
L. M. Nordstrand (2007)
10.1021/JO062446P
How to compute isomerization energies of organic molecules with quantum chemical methods.
S. Grimme (2007)
GeneChip Arrays
Affymetrix Corporation. (2007)
Gene Chip Arrays. Affymetrix Corporation
(2007)
The future of drug safety: Promoting and protecting the health of the public
Institute of Medicine. (2007)
Affymetrix Corporation
(2007)
Genetic and epigenetic changes induced by chronic low dose exposure to arsenic
K. P. Singh (2007)
10.1111/j.1749-0774.2005.tb00005.x
Loss of integrin α3 expression is associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cells
N. Suzuki (2011)
10.1111/j.1749-0774.2006.00011.x
Establishment and therapeutic use of human embryonic stem cell lines
H. Suemori (2011)
TOXICOKINETICS AND METABOLISM
T. Furukawa
MAP Kinase Phosphatase As a Locus of Flexibility in a Mitogen-Activated Protein Kinase Signaling Network
E. Wimmer
The role of mutagenicity in describing formaldehyde
R P Subramaniam
Government Accounting Office
Dc U S Washington
The role of mutagenicity in describing formaldehyde-induced carcinogenicity: Possible inferences using the CIIT model. Presented at the Society of Risk Analysis Annual Meeting
R P Subramaniam



This paper is referenced by
10.1016/j.bja.2021.03.009
Applying the adverse outcome pathway concept to questions in anaesthetic neurotoxicity.
Jennifer Waspe (2021)
10.1016/j.crtox.2021.08.003
Use of a rapid human primary cell-based disease screening model, to compare next generation products to combustible cigarettes
L. Simms (2021)
10.1016/j.crtox.2021.05.002
In vitro prediction of clinical signs of respiratory toxicity in rats following inhalation exposure
E. Da Silva (2021)
10.1093/nar/gkaa1027
Open Targets Platform: supporting systematic drug–target identification and prioritisation
D. Ochoa (2021)
10.1038/s41540-020-00166-2
High-throughput toxicogenomic screening of chemicals in the environment using metabolically competent hepatic cell cultures
Jill A. Franzosa (2021)
10.1039/d0an02212h
Approaches in metabolomics for regulatory toxicology applications.
E. Olesti (2021)
10.1038/s41598-021-82711-5
Evaluation of an in vitro assay to screen for the immunotoxic potential of chemicals to fish
Kristina Rehberger (2021)
10.1016/j.reprotox.2021.02.006
Does the food processing contaminant acrylamide cause developmental neurotoxicity? A review and identification of knowledge gaps.
B. Lindeman (2021)
10.1016/j.envpol.2021.116541
Comprehensive analysis of organophosphorus flame retardant-induced mitochondrial abnormalities: Potential role in lipid accumulation.
Yifei Le (2021)
10.1177/2397847321992752
An interlaboratory in vitro aerosol exposure system reference study
D. Thorne (2021)
10.1007/s00204-021-02992-7
Nanoparticle-induced inflammation and fibrosis in ex vivo murine precision-cut liver slices and effects of nanoparticle exposure conditions
R. Bartucci (2021)
10.1016/B978-0-12-820490-0.00009-2
A Systems-Based Approach to Toxicity Testing
J. Hoeng (2021)
10.1016/j.crtox.2021.05.005
An adverse outcome pathway for lung surfactant function inhibition leading to decreased lung function
É. da Silva (2021)
10.1016/j.comtox.2020.100147
Extrapolation of drug induced liver injury responses from cancer cell lines using machine learning approaches
Alejandro Aguayo-Orozco (2021)
10.1016/j.jhazmat.2020.123724
Quantitative structure-toxicity relationship model for acute toxicity of organophosphates via multiple administration routes in rats and mice.
L. Wang (2021)
10.1038/s42003-021-01990-w
Multi-omics phenotyping of the gut-liver axis reveals metabolic perturbations from a low-dose pesticide mixture in rats
R. Mesnage (2021)
10.1016/J.ENVADV.2021.100061
Envisioning an International Validation Process for New Approach Methodologies in Chemical Hazard and Risk Assessment
Matthieu Mondou (2021)
10.1007/s00204-021-03056-6
Ensemble machine learning to evaluate the in vivo acute oral toxicity and in vitro human acetylcholinesterase inhibitory activity of organophosphates.
Liangliang Wang (2021)
10.1016/j.crtox.2021.07.003
Reproducibility and robustness of high-throughput S1500+ transcriptomics on primary rat hepatocytes for chemical-induced hepatotoxicity assessment
Fann Lee (2021)
10.1101/2021.01.22.427848
Identifying the Link Between Chemical Exposures and Breast Cancer in African American Women via ToxCast High Throughput Screening Data
Katelyn Polemi (2021)
10.1016/B978-0-12-821038-3.00071-9
Genotoxicity evaluation of nutraceuticals
N. Mei (2021)
10.1016/B978-0-12-820490-0.00018-3
Toxicological Assessment In Vitro
C. Poussin (2021)
10.1016/j.aca.2021.338298
Metabolomics in chemical risk analysis - A review.
M. Hernández-Mesa (2021)
10.1016/j.scitotenv.2021.145577
Applications of advanced neuro-behavioral analysis strategies in aquatic ecotoxicology.
A. Bownik (2021)
10.1016/j.patter.2021.100227
HCGA: Highly comparative graph analysis for network phenotyping
R. Peach (2021)
10.1093/toxsci/kfaa036
Targeted pathway-based in vivo testing using thyroperoxidase inhibition to evaluate plasma thyroxine as a surrogate metric of metamorphic success in model amphibian Xenopus laevis.
Jonathan T Haselman (2020)
10.1002/ieam.4244
Factors affecting the perception of New Approach Methodologies (NAMs) in the ecotoxicology community.
Matthieu Mondou (2020)
10.1007/s10098-019-01795-w
An automated framework for compiling and integrating chemical hazard data
Leora Vegosen (2020)
10.1016/j.cbd.2020.100655
Characterizing physical protein targets of chemical contaminants with chemical proteomics: Is it time to fill a crucial environmental toxicology knowledge gap?
D. R. Hall (2020)
10.1021/acs.chemrestox.0c00104
Distinct Orchestration and Dynamic Processes on γ-H2AX and p-H3 for Two Major Types of Genotoxic Chemicals Revealed by Mass Spectrometry Analysis.
Minmin Qu (2020)
10.1007/s00204-020-02902-3
Multiple-endpoint in vitro carcinogenicity test in human cell line TK6 distinguishes carcinogens from non-carcinogens and highlights mechanisms of action
K. E. Chapman (2020)
10.1016/j.tox.2020.152421
The way forward for assessing the human health safety of cosmetics in the eu workshop proceedings.
V. Rogiers (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar